Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: A multinational study

Journal of Clinical Oncology

Volumn 29, Issue 10, 2011, Pages 1297-1303

  Kurita, Geana P ^a   Sjøgren, Per ^a   Ekholm, Ola ^a   Kaasa, Stein ^a   Loge, Jon H ^a   Poviloniene, Irena ^a   Klepstad, Pål ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; FENTANYL; GABAPENTIN; HYPNOTIC AGENT; MORPHINE; OPIATE; OXYCODONE; PREGABALIN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; BODY MASS; BREAKTHROUGH PAIN; BREAST CANCER; CANCER DIAGNOSIS; CANCER PAIN; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEAD AND NECK CANCER; HEMATOLOGIC MALIGNANCY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; PAIN; PANCREAS CANCER; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; RISK FACTOR; SARCOMA; SCORING SYSTEM; SKIN CANCER; TREATMENT DURATION; URINARY TRACT CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; PAIN; PAIN MEASUREMENT; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 79953850292     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.6884     Document Type: Article

References (60)

1. Derogatis LR, Morrow GR, Fetting J, et al: The prevalence of psychiatric disorders among cancer patients. JAMA 249:751-757, 1983 (Pubitemid 13186788)
2. Ventafridda V, Ripamonti C, De Conno F, et al: Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7-11, 1990
3. Stiefel F, Holland J: Delirium in cancer patients. Int Psychogeriatry 3:333-336, 1991
4. Strömgren AS, Goldschmidt D, Groenvold M, et al: Self-assessment in cancer patients referred to palliative care: A study of feasibility and symptom epidemiology. Cancer 94:412-520, 2002
5. Levine PM, Silberfarb PM, Lipowski ZJ: Mental disorders in cancer patients: A study of 100 psychiatric referrals. Cancer 42:1385-1391, 1978 (Pubitemid 9047450)
6. Massie MJ, Holland J, Glass E: Delirium in terminally ill cancer patients. Am J Psychiatry 140:1048-1050, 1983 (Pubitemid 13028678)
7. Sjøgren P: Psychomotor and cognitive functioning in cancer patients. Acta Anaesthesiol Scand 41:159-161, 1997
8. Sjøgren P, Olsen AK, Thomsen AB, et al: Neuropsychological performance in cancer patients: The role of oral opioids, pain and performance status. Pain 86:237-245, 2000 (Pubitemid 30254264)
9. Banning A, Sjøgren P: Cerebral effects of longterm oral opioids in cancer patients measured by continuous reaction time. Clin J Pain 6:91-95, 1990 (Pubitemid 20342851)
10. McCracken LM, Iverson GL: Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 21:392-396, 2001 (Pubitemid 32452139)
11. Pereira J, Hanson J, Bruera E: The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 79:835-842, 1997 (Pubitemid 27076350)
12. Bruera E, Macmillan K, Hanson J, et al: The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 39:13-16, 1989 (Pubitemid 19258904)
13. Chapman SL, Byas-Smith MG, Reed BA: Effects of intermediate- and long-term use of opioids on cognition in patients with chronic pain. Clin J Pain 18:S83-S90, 2002 (suppl 4) (Pubitemid 34815398)
14. Vainio A, Ollila J, Matikainen E, et al: Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 346:667-670, 1995
15. Kurita GP, de Mattos Pimenta CA: Cognitive impairment in cancer pain patients receiving opioids: A pilot study. Cancer Nurs 31:49-57, 2008
16. Sjøgren P, Banning A, Christensen CB, et al: Continuous reaction time after single dose, longterm oral and epidural opioid administration. Eur J Anaesthesiol 11:95-100, 1994 (Pubitemid 24085532)
17. Sjøgren P, Banning A: Pain, sedation and reaction time during long-term treatment of cancer patients with oral and epidural opioids. Pain 39:5-11, 1989 (Pubitemid 19258903)
18. Lussier D, Huskey AG, Portenoy RK: Adjuvant analgesics in cancer pain management. Oncologist 9:571-591, 2004 (Pubitemid 39332322)
19. Folstein MF, Fetting JH, Lobo A, et al: Cognitive assessment of cancer patients. Cancer 53: 2250-2257, 1984 (Pubitemid 14136878)
20. Crum RM, Anthony JC, Bassett SS, et al: Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA 269:2386-2391, 1993 (Pubitemid 23129378)
21. Fayers PM, Hjermstad MJ, Ranhoff AH, et al: Which mini-mental state exam items can be used to screen for delirium and cognitive impairment? J Pain Symptom Manage 30:41-50, 2005
22. Mystakidou K, Tsilika E, Parpa E, et al: Brief cognitive assessment of cancer patients: Evaluation of the Mini-Mental State Examination (MMSE) psychometric properties. Psychooncology 16:352-357, 2007 (Pubitemid 46681105)
23. Lawlor PG, Gagnon B, Mancini IL, et al: Occurrence, causes, and outcome of delirium in patients with advanced cancer: A prospective study. Arch Intern Med 160:786-794, 2000 (Pubitemid 30165239)
24. Grassi L, Caraceni A, Beltrami E, et al: Assessing delirium in cancer patients: The Italian versions of the Delirium Rating Scale and the Memorial Delirium Assessment Scale. J Pain Symptom Manage 21:59-68, 2001 (Pubitemid 32149664)
25. Massa E, Madeddu C, Lusso MR, et al: Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Crit Rev Oncol Hematol 57:175-182, 2006 (Pubitemid 43139702)
26. Irwin SA, Zurhellen CH, Diamond LC, et al: Unrecognised cognitive impairment in hospice patients: A pilot study. Palliat Med 22:842-847, 2008
27. WorldHealthOrganization:BMIclassification. http://apps.who.int/bmi/index. jsp?introPage=intro-3.html
28. Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 2:187-193, 1984 (Pubitemid 14138407)
29. Karnofsky DA, Burchenal JH: The clinical evaluation of chemotherapeutic agents in cancer, in MacLeod CM (ed): Evaluation of Chemotherapeutic Agents. New York, NY, Columbia University Press, 1949, p 196
30. Fainsinger RL, Nekolaichuk CL, Lawlor PG, et al: A multicenter study of the Revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29:224-237, 2005 (Pubitemid 40386739)
31. Cleeland CS, Ryan KM: Pain assessment: Global use of the Brief Pain Inventory. Ann Acad Med Singapore 23:129-138, 1994
32. American College of Physicians: Dosing and conversion chart for opioid analgesics. http://www.acponline.org/clinical-information/journals-publications/ acp-internist/dec04/pain/dosing-conv.pdf
33. Lawlor PG, Turner KS, Hanson J, et al: Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 82:1167-1173, 1998 (Pubitemid 28136533)
34. Benedetti C, Butler SH: Systemic analgesics, in Bonica JJ, Loeser JD, Chapman CR, et al (eds): The Management of Pain (ed 2). Philadelphia, PA, Lea and Febiger, 1990, pp 1640-1675
35. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993 (Pubitemid 23073154)
36. Stokes ME, Davis CS, Koch GG: Categorical Data Analysis Using the SAS System (ed 2). Cary, NC, SAS Publishing, 2000
37. Klee M, Groenvold M, Machin D: Using data from studies of health-related quality of life to describe clinical issues: Examples from a longitudinal study of patients with advanced stages of cervical cancer. Qual Life Res 8:733-742, 1999 (Pubitemid 30331121)
38. Hjermstad MJ, Loge JH, Kaasa S: Methods for assessment of cognitive failure and delirium in palliative care patients: Implications for practice and research. Palliat Med 18:494-506, 2004 (Pubitemid 39242796)
39. Kamboj SV, Tookman A, Jones L, et al: The effects of immediate-release morphine on cognitive functioning in patients receiving chronic opioid therapy in palliative care. Pain 117:388-395, 2005 (Pubitemid 41383533)
40. Klepstad P, Hilton P, Moen J, et al: Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to a palliative care unit. Palliat Med 16:513-519, 2002 (Pubitemid 35386010)
41. Meyers CA, Wefel JS: The use of the Mini- Mental State Examination to assess cognitive functioning in cancer trails: No ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557-3558, 2003 (Pubitemid 46594045)
42. Bruera E, Miller L, McCallion J, et al: Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 7:192-195, 1992
43. Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: A comprehensive review. J Am Geriatr Soc 40:922-935, 1992
44. Mancuso A, Migliorino M, De Santis S, et al: Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Ann Oncol 17:146-150, 2006 (Pubitemid 43033855)
45. Whitney KA, Lysaker PH, Steiner AR, et al: Is "chemobrain" a transient state? A prospective pilot study among persons with non-small cell lung cancer. J Support Oncol 6:313-321, 2008
46. Grosshans DR, Meyers CA, Allen PK, et al: Neurocognitive function in patients with small cell lung cancer: Effect of prophylactic cranial irradiation. Cancer 112:589-595, 2008 (Pubitemid 351186199)
47. Banning A, Sjøgren P, Kaiser F: Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids. Acta Anaesthesiol Scand 36:480-482, 1992
48. Chin AV, O'Connell H, Kirby M, et al: Co-morbid and socio-demographic factors associated with cognitive performance in an elderly community dwelling Irish population. Int J Geriatr Psychiatry 21:1150-1155, 2006 (Pubitemid 46029218)
49. Lundorff L, Peuckmann V, Sjøgren P: Pain management of opioid-treated cancer patients in hospital settings in Denmark. Acta Anaesthesiol Scand 52:137-142, 2008
50. Kurita GP, Lundorff L, Pimenta CA, et al: The cognitive effects of opioids in cancer: A systematic review. Support Care Cancer 17:11-21, 2009
51. Daeninck PJ, Bruera E: Opioid use in cancer pain: Is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand 43:924-938, 1999
52. de Stoutz ND, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378-384, 1995
53. Mercadante S, Bruera E: Opioid switching: A systematic and critical review. Cancer Treat Rev 32:304-315, 2006 (Pubitemid 44502005)
54. Zacny JP, Lichtor SA: Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers. Psychopharmacology (Berl) 196:105-116, 2008
55. Hunt R, Fazekas B, Thorne D, et al: A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 18:111-119, 1999 (Pubitemid 29409439)
56. O'Neill WM, Hanks GW, Simpson P, et al: The cognitive and psychomotor effects of morphine in healthy subjects: A randomised controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo. Pain 85:209-215, 2000 (Pubitemid 30110761)
57. Stewart SA: The effects of benzodiazepines on cognition. J Clin Psychiatry 66:S9-S13, 2005 (suppl 2)
58. Brooks JO, Hoblyn JC: Neurocognitive costs and benefits of psychotropic medications in older adults. J Geriatr Psychiatry Neurol 20:199-214, 2007
59. Eccleston C: Chronic pain and attention: A cognitive approach. Br J Clin Psychol 33:535-547, 1994
60. Shega JW, Paice JA, Rockwood K, et al: Is the presence of mild to moderate cognitive impairment associated with self-report of non-cancer pain? A cross-sectional analysis of a large population-based study. J Pain Symptom Manage 39:734-742, 2010